Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared Nick James‘s, Professor of Prostate and Bladder Cancer Research at The Institute of Cancer Research, post on X, adding:
“MRI should be a routine for daily management of MIBC. cCR definition and modern bladder-sparing strategies will rely on it. Congratulations a step forward to this direction.”
Quoting Nick James’s post:
“Out today, the full report on BladderPath – MRI directed staging for newly diagnosed bladder cancer vs TURBT. Early use of MRI halves time to treatment for MIBC. Time to rethink the staging pathway.”
Source: Andrea Necchi/X and Nick James/X